Abstract:Objective: Low-molecular weight chromium compounds, such as chromium picolinate [Cr(pic)(3)] improve insulin sensitivity, although toxicity is a concern. We synthesized a novel chromium complex, chromium (D-phenylalanine)(3) [Cr(D-phe)(3)], in an attempt to improve insulin sensitivity with reduced toxicity. The aim of this study was to compare the two chromium compounds on cardiac contractile function in ob/ob obese mice.Research Methods and Procedures: C57BL lean and ob/ob obese mice were randomly divided into three groups: H2O, Cr(D-phe)(3), or Cr(pic)(3) (45 mu g/kg per day orally for 6 months).Results: The glucose tolerance test displayed improved glucose clearance by Cr(D-phe)(3) but not Cr(pic)(3)- Myocytes from ob/ob mice exhibited depressed peak shortening (PS) and maximal velocity of shortening/relengthening (+/- dL/dt), prolonged time-to-PS and time-to-90% relengthening (TR90), reduced electrically stimulated rise in intracellular Ca (2+) (Delta fura-2 fluorescence intensity), and slowed intracellular Ca2+ decay. Although a 3-month Cr(D-phe)3 treatment for a separate group of ob/ob and lean 2-month-old mice only rectified reduced +/- dL/dt in oblob mice, all mechanical and intracellular Ca (2+) abnormalities were significantly attenuated or ablated by 6 months of Cr(D-phe)(3) but not Cr(pic)(3) treatment (except TR90). Sarco(endo)plasmic reticulum Ca (2+) ATPase activity and Na+-Ca (2+) exchanger expression were depressed in oblob mice, which were reversed by both Cr(D-phe)(3) and Cr(pic(3)) with a more pronounced effect from Cr(D-phe)(3) Cr(D-phe)(3) corrected reduced insulin-stimulated glucose uptake and improved basal phosphorylation of Akt and insulin receptor, as well as insulin-stimulated phosphorylation of Akt and insulin receptor in oblob myocytes. Heart homogenates from oblob mice had enhanced oxidative stress and protein carbonyl formation compared with the lean group, which were attenuated by both Cr(D-phe)(3) and Cr(piC)(3)Discussion: Our data suggest that the new Cr(D-phe)(3) Compound possesses better cardio-protective and insulin-sensitizing properties against obesity.

Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats.

Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats.

Effect of chromium picolinate on insulin sensitivity in vivo

Chromium Improves Protein Deposition Through Regulating the mRNA Levels of IGF-1, IGF-1R, and Ub in Rat Skeletal Muscle Cells

Chromium(D-Phenylalanine)(3) Improves Obesity-Induced Cardiac Contractile Defect in Ob/Ob Mice

Chromium Improves Glucose Uptake and Metabolism Through Upregulating the Mrna Levels of Ir, Glut4, Gs, and Ucp3 in Skeletal Muscle Cells

Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic Er Stress in Obese Mice

Chromium (d-Phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities

Chromium (D-Phenylalanine)3 Supplementation Alters Glucose Disposal, Insulin Signaling, and Glucose Transporter-4 Membrane Translocation in Insulin-Resistant Mice.

Chromium-insulin Reduces Insulin Clearance and Enhances Insulin Signaling by Suppressing Hepatic Insulin-Degrading Enzyme and Proteasome Protein Expression in KKAy Mice

Combined Chromium and Magnesium Decreases Insulin Resistance More Effectively Than Either Alone.

A Newly Synthetic Chromium Complex – Chromium(phenylalanine)3 Improves Insulin Responsiveness and Reduces Whole Body Glucose Tolerance

Chromium Picolinate Inhibits Resistin Secretion in Insulin-Resistant 3T3-L1 Adipocytes Via Activation of Amp-Activated Protein Kinase.

Insulin-Sensitizing and Cholesterol-Lowering Effects of Chromium (D-Phenylalanine)(3)

Effect of Chromium Picolinate on Body Weight and Lipid Metabolism of Obese Rats Induced by High Energy Food

A Newly Synthetic Chromium Complex—chromium (D-Phenylalanine)3 Activates AMP-activated Protein Kinase and Stimulates Glucose Transport

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats

Characterization of the Metabolic and Physiologic Response to Chromium Supplementation in Subjects with Type 2 Diabetes Mellitus

Phenotype of Subjects with Type 2 Diabetes Mellitus May Determine Clinical Response to Chromium Supplementation

Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice.

Chromium Picolinate Enhanced CD36 Translocation Through AMPK Pathway in 3T3L1 Adipocytes